Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT05133245

PHACE - Prospective Genetic Investigation

Investigation for potential PHACE syndrome gene.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Vanderbilt Eye Institute

Nashville, Tennessee, 37232, United States

About this study

Subjects with PHACE syndrome diagnosis will undergo a brief physical examination with possible external photographs. Cheek swabs will be sent for genetic analysis. Subjects will be notified of the results.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • PHACE syndrome diagnosis
  • Must be willing to have an eye examination
  • Must be willing to undergo genetic testing

Exclusion criteria

  • No PHACE syndrome diagnosis

Treatment and study plan

Diagnostic study only

Other

Diagnostic study only

Primary outcomes

  1. Potential PHACE Gene Identification

    Time frame: 3 years

    Evaluation for potential PHACE gene

Sponsors and collaborators

Lead sponsor

Vanderbilt University Medical Center

Other

Registry information

Acronym: PHACE

Important dates

Study start
2021
Primary completion
2026
Study completion
2026
First posted
Nov 24, 2021
Registry last updated
Dec 23, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.